GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ISU Abxis Co Ltd (XKRX:086890) » Definitions » Issuance of Debt

ISU Abxis Co (XKRX:086890) Issuance of Debt : ₩1,022 Mil (TTM As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is ISU Abxis Co Issuance of Debt?

ISU Abxis Co's Issuance of Debt for the three months ended in Dec. 2024 was ₩0 Mil.

ISU Abxis Co's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was ₩1,022 Mil.


ISU Abxis Co Issuance of Debt Historical Data

The historical data trend for ISU Abxis Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ISU Abxis Co Issuance of Debt Chart

ISU Abxis Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 80,000.00 - 49,363.51 -

ISU Abxis Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,021.97 - - -

ISU Abxis Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,022 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ISU Abxis Co Issuance of Debt Related Terms

Thank you for viewing the detailed overview of ISU Abxis Co's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


ISU Abxis Co Business Description

Traded in Other Exchanges
N/A
Address
3Fl. Kookje Bldg, 90-1 Daeshin-dong, Seodaemun-gu, Seoul, KOR, 120-160
ISU Abxis Co Ltd is engaged in developing and manufacturing therapeutic antibodies in South Korea. It offers Abciximab, Clotinab, Abcertin, and Fabagal used to treat incurable diseases such as cancer and rare diseases.

ISU Abxis Co Headlines

No Headlines